Association between thyroid disease and its treatment with ANCA small-vessel vasculitis: A case-control study

Nephrology Dialysis Transplantation

Volumn 22, Issue 12, 2007, Pages 3508-3515

  Lionaki, Sofia ^a,b   Hogan, Susan L ^a   Falk, Ronald J ^a   Joy, Melanie S ^a   Chin, Hyunsook ^a   Jennette, Caroline E ^a   Jennette, J Charles ^a   Nachman, Patrick H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOBLASTIN; MYELOPEROXIDASE; PROPYLTHIOURACIL; THIAMAZOLE;

ADULT; AGED; ANAMNESIS; ANCA ASSOCIATED VASCULITIS; ARTICLE; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS BASEMENT MEMBRANE; HUMAN; KIDNEY BIOPSY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; STRUCTURED INTERVIEW; THYROID DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; THYROID DISEASES; VASCULITIS;

EID: 36749009179     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm493     Document Type: Article

References (52)

1. Shoenfeld Y, Isenberg DA. The mosaic of autoimmunity. Immunol Today 1989; 10: 123-126
2. Shoenfeld Y. The kaleidoscope of autoimmunity. Autoimmunity 1993; 15: 245-252
3. Lorber M, Gershwin ME, Shoenfeld Y. The coexistence of systemic lupus erythematosus with other autoimmune diseases: the kaleidoscope of autoimmunity. Semin Arthritis Rheum 1994; 24: 105-113
4. Szyper-Kravitz M, Marai I, Shoenfeld Y. Coexistence of thyroid autoimmunity with other autoimmune diseases: friend or foe? Additional aspects on the mosaic of autoimmunity. Autoimmunity 2005; 38: 247-255
5. Aune TM, Maas K, Parker J, Moore JH, Olsen NJ. Profiles of gene expression in human autoimmune disease. Cell Biochem Biophys 2004; 40: 81-96
6. Zhuang H, Kosboth M, Lee P et al. Lupus-like disease and high interferon levels corresponding to trisomy of the type I interferon cluster on chromosome 9p. Arthritis Rheum 2006; 54: 1573-1579
7. Peterson KS, Huang JF, Zhu J et al. Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J Clin Invest 2004; 113: 1722-1733
8. ten Holder SM, Joy MS, Falk RJ. Cutaneous and systemic manifestations of drug-induced vasculitis. Ann Pharmacother 2002; 36: 130-147
9. Stone JH. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial. Arthritis Rheum 2003; 48: 2299-2309
10. Hogan SL, Cooper GC, Savitz DA et al. Association of silica exposure with ANCA-associated glomerulonephritis: a population-based case-control study in the Southeastern United States. Clin J Am Soc Nephrol 2007; 2: 290-299
11. Hauer HA, Bajema IM, van Houwelingen HC et al. Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int 2002; 61: 80-89
12. Hagen EC, Daha MR, Hermans J et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization [see comments]. Kidney Int 1998; 53: 743-753
13. Nifli AP, Notas G, Mamoulaki M et al. Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum. J Immunol Methods 2006; 311: 189-197
14. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-192
15. Hogan SL, Falk RJ, Chin H et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 2005; 143: 621-631
16. Luqmani RA, Bacon PA, Moots RJ et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med 1994; 87: 671-678
17. Tanaka A, Maeda K, Sawai K, Okuda J, Sugawara A, Kuwahara T. Concealed hypothyroidism in patients with myeloperoxidase antineutrophil cytoplasmic autoantibodies. Clin Nephrol 1999; 52: 91-95
18. Afeltra A, Paggi A, De Rosa FG, Manfredini P, Addessi MA, Amoroso A. Antineutrophil cytoplasmic antibodies in autoimmune thyroid disorders. Endocr Res 1998; 24: 185-194
19. Masor JJ, Gal AA, LiVolsi VA. Case report: Hashimoto's thyroiditis associated with Wegener's granulomatosis. Am J Med Sci 1994; 308: 112-114
20. Raillard-Gohin H, Leray-Moragues H, Canaud B, Pages M. Systemic vasculitis and hyperthyroidism in a patient with myasthenia gravis. J Neurol 2001; 248: 525-526
21. Wang C, Crapo LM. The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am 1997; 26: 189-218
22. Cooper DS, Ridgway EC. Thoughts on prevention of thyroid disease in the United States. Thyroid 2002; 12: 925-929
23. Douglas G, Bird K, Flume P, Silver R, Bolster M. Wegener's granulomatosis in patients with rheumatoid arthritis. J Rheumatol 2003; 30: 2064-2069
24. Yoshida M. [Intractable renal vasculitis by lupus nephritis and ANCA associated vasculitis]. Nihon Rinsho Meneki Gakkai Kaishi 2004; 27: 137-144
25. Muller E, Schneider W, Kettritz U, Schmidt WA, Luft FC, Gobel U. Temporal arteritis with pauci-immune glomerulonephritis: a systemic disease. Clin Nephrol 2004; 62: 384-386
26. Radaelli F, Meucci G, Spinzi G et al. Acute self-limiting jejunitis as the first manifestation of microscopic polyangiitis associated with Sjogren's disease: report of one case and review of the literature. Eur J Gastroenterol Hepatol 1999; 11: 931-934
27. Rodriguez-Reyna TS, Alarcon-Segovia D. Overlap syndromes in the context of shared autoimmunity. Autoimmunity 2005; 38: 219-223
28. Kotsa K, Watson PF, Weetman AP. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism. Clin Endocrinol (Oxf) 1997; 46: 551-554
29. Tomer Y. Unraveling the genetic susceptibility to autoimmune thyroid diseases: CTLA-4 takes the stage. Thyroid 2001; 11: 167-169
30. Giscombe R, Wang X, Huang D, Lefvert AK. Coding sequence 1 and promoter single nucleotide polymorphisms in the CTLA-4 gene in Wegener's granulomatosis. J Rheumatol 2002; 29: 950-953
31. Huang D, Giscombe R, Zhou Y, Lefvert AK. Polymorphisms in CTLA-4 but not tumor necrosis factor-alpha or interleukin 1beta genes are associated with Wegener's granulomatosis. J Rheumatol 2000; 27: 397-401
32. Zhou Y, Huang D, Paris PL, Sauter CS, Prock KA, Hoffman GS. An analysis of CTLA-4 and proinflammatory cytokine genes in Wegener's granulomatosis. Arthritis Rheum 2004; 50: 2645-2650
33. Gaches F, Delaire L, Nadalon S, Loustaud-Ratti V, Vidal E. [Frequency of autoimmune diseases in 218 patients with autoimmune thyroid pathologies]. Rev Med Interne 1998; 19: 173-179
34. Biro E, Szekanecz Z, Czirjak L et al. Association of systemic and thyroid autoimmune diseases. Clin Rheumatol 2006; 25: 240-245
35. Brand O, Gough S, Heward J. HLA, CTLA-4 and PTPN22: the shared genetic master-key to autoimmunity? Expert Rev Mol Med 2005; 7: 1-15
36. Mustelin T. Are other protein tyrosine phosphatases than PTPN22 associated with autoimmunity? Semin Immunol 2006; 18: 254-260
37. Corapcioglu D, Tonyukuk V, Kiyan M et al. Relationship between thyroid autoimmunity and Yersinia enterocolitica antibodies. Thyroid 2002; 12: 613-617
38. Stegeman CA, Cohen Tervaert JW, Manson WL, Smeets H, De Jong PE, Kallenberg CG. Chronic nasal carriage of Staphylococcal aureus in Wegener's granulomatosis identifies a subgroup of patients more prone to relapse. Ann Intern Med 1994; 120: 12-17
39. Prummel MF, Strieder T, Wiersinga WM. The environment and autoimmune thyroid diseases. Eur J Endocrinol 2004; 150: 605-618
40. Schuurs AH, Verheul HA. Effects of gender and sex steroids on the immune response. J Steroid Biochem 1990; 35: 157-172
41. Cutolo M, Sulli A, Villaggio B, Seriolo B, Accardo S. Relations between steroid hormones and cytokines in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 1998; 57: 573-577
42. Booth AD, Almond MK, Burns A et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 2003; 41: 776-784
43. de Groot K, Rasmussen N, Bacon PA et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005; 52: 2461-2469
44. Rapoport B, McLachlan SM. Thyroid autoimmunity. J Clin Invest 2001; 108: 1253-1259
45. Bresson D, Cerutti M, Devauchelle G et al. Localization of the discontinuous immunodominant region recognized by human anti-thyroperoxidase autoantibodies in autoimmune thyroid diseases. J Biol Chem 2003; 278: 9560-9569
46. Hobby P, Gardas A, Radomski R, McGregor AM, Banga JP, Sutton BJ. Identification of an immunodominant region recognized by human autoantibodies in a three-dimensional model of thyroid peroxidase. Endocrinology 2000; 141: 2018-2026
47. Guo J, McLachlan SM, Rapoport B. Localization of the thyroid peroxidase autoantibody immunodominant region to a junctional region containing portions of the domains homologous to complement control protein and myeloperoxidase. J Biol Chem 2002; 277: 40189-40195
48. Freire BA, Paula ID, Paula F, Kallenberg CG, Limburg PC, Queluz TT. Absence of cross-reactivity to myeloperoxidase of anti-thyroid microsomal antibodies in patients with autoimmune thyroid diseases. Am J Med Sci 2001; 321: 109-112
49. Slot MC, Links TP, Stegeman CA, Tervaert JW. Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: A long-term follow-up study. Arthritis Rheum 2005; 53: 108-113
50. Guma M, Olive A, Juan M, Salinas I. ANCA antibodies in Graves' disease. Ann Rheum Dis 2002; 61: 90-91
51. Franssen CF, Hoorntje SJ, Kallenberg CG, Gans RO. [The role of perinuclear antineutrophil granulocytes cytoplasmic antibodies in the diagnosis of vasculitis and chronic inflammatory diseases (see comments)]. Ned Tijdschr Geneeskd 1996; 140: 2076-2082
52. Falk RJ, Moore DT, Hogan SL, Jennette JC. A renal biopsy is essential for the management of ANCA-positive patients with glomerulonephritis. Sarcoidosis Vasc Diffuse Lung Dis 1996; 13: 230-231